Inhibin B and anti-Müllerian hormone as markers of persistent spermatogenesis in men with non-obstructive azoospermia: A meta-analysis of diagnostic accuracy studies

Human Reproduction Update

Volumn 16, Issue 6, 2010, Pages 713-724

  Toulis, Konstantinos A ^a   Iliadou, Paschalia K ^a   Venetis, Christos A ^a   Tsametis, Christos ^a   Tarlatzis, Basil C ^a   Papadimas, Ioannis ^a   Goulis, Dimitrios G ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Assisted reproduction; Counseling; Diagnostic accuracy studies; Endocrinocology; ICSI; Infertility; Sperm retrieval; Spermatogenesis

Indexed keywords

BIOLOGICAL MARKER; INHIBIN B; MUELLERIAN INHIBITING FACTOR;

ARTICLE; AZOOSPERMIA; CLINICAL TRIAL; COCHRANE LIBRARY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EMBASE; HUMAN; MALE; MEDLINE; META ANALYSIS; NON OBSTRUCTIVE AZOOSPERMIA; PRIORITY JOURNAL; SEMINAL VESICLE; SENSITIVITY AND SPECIFICITY; SPERMATOGENESIS; SYSTEMATIC REVIEW; TESTICULAR SPERM EXTRACTION;

ANTI-MULLERIAN HORMONE; AZOOSPERMIA; HUMANS; INHIBINS; MALE; PREDICTIVE VALUE OF TESTS; SPERMATOGENESIS;

EID: 78649353357     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmq024     Document Type: Article

References (65)

1. Al-Qahtani A, Muttukrishna S, Appasamy M, Johns J, Cranfield M, Visser JA, Themmen AP, Groome NP. Development of a sensitive enzyme immunoassay for anti-Mullerian hormone and the evaluation of potential clinical applications in males and females. Clin Endocrinol (Oxf) 2005;63:267-273.
2. Anawalt BD, Bebb RA, Matsumoto AM, Groome NP, Illingworth PJ, McNeilly AS, Bremner WJ. Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J Clin Endocrinol Metab 1996;81:3341-3345.
3. Appasamy M, Muttukrishna S, Pizzey AR, Ozturk O, Groome NP, Serhal P, Jauniaux E. Relationship between male reproductive hormones, sperm DNA damage and markers of oxidative stress in infertility. Reprod Biomed Online 2007;14:159-165.
4. Bailly M, Guthauser B, Bergere M, Wainer R, Lombroso R, Ville Y, Selva J. Effects of low concentrations of inhibin B on the outcomes of testicular sperm extraction and intracytoplasmic sperm injection. Fertil Steril 2003; 79:905-908.
5. Ballesca JL, Balasch J, Calafell JM, Alvarez R, Fabregues F, de Osaba MJ, Ascaso C, Vanrell JA. Serum inhibin B determination is predictive of successful testicular sperm extraction in men with non-obstructive azoospermia. Hum Reprod 2000;15:1734-1738.
6. Bettella A, Ferlin A, Menegazzo M, Ferigo M, Tavolini IM, Bassi PF, Foresta C. Testicular fine needle aspiration as a diagnostic tool in non-obstructive azoospermia. Asian J Androl 2005;7:289-294.
7. Bohring C, Krause W. Serum levels of inhibin B in men with different causes of spermatogenic failure. Andrologia 1999;31:137-141.
8. Bohring C, Schroeder-Printzen I, Weidner W, Krause W. Serum levels of inhibin B and follicle-stimulating hormone may predict successful sperm retrieval in men with azoospermia who are undergoing testicular sperm extraction. Fertil Steril 2002;78:1195-1198.
9. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Moher D, Rennie D, de Vet HC, Lijmer JG. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 2003;138:W1-W12.
10. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006;12:685-718.
11. Brugo-Olmedo S, De Vincentiis S, Calamera JC, Urrutia F, Nodar F, Acosta AA. Serum inhibin B may be a reliable marker of the presence of testicular spermatozoa in patients with nonobstructive azoospermia. Fertil Steril 2001;76:1124-1129.
12. Deeks JJ. Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ 2001;323:157-162.
13. Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ 2004; 329:168-169.
14. Dong ZY, Zhang RL, He ZX, Sun HC. Relationship between pathological alterations of spermatogenic impairment and serum inhibin B concentration in patients with azoospermia. Zhonghua Nan Ke Xue 2006;12:18-20, 24.
15. Donoso P, Tournaye H, Devroey P. Which is the best sperm retrieval technique for non-obstructive azoospermia? A systematic review. Hum Reprod Update 2007;13:539-549.
16. Duvilla E, Lejeune H, Trombert-Paviot B, Gentil-Perret A, Tostain J, Levy R. Significance of inhibin B and anti-Mullerian hormone in seminal plasma: a preliminary study. Fertil Steril 2008;89:444-448.
17. Dwamena BA. MIDAS: Stata module for meta-analytical integration of diagnostic test accuracy studies. Statistical Software Components. Boston College Department of Economics, 2007.
18. El Garem YF, El Arini AF, El Beheiry AH, Zeid SA, Comhaire FH. Possible relationship between seminal plasma inhibin B and spermatogenesis in patients with azoospermia. J Androl 2002;23:825-829.
19. Fagan TJ. Letter: Nomogram for Bayes theorem. N Engl J Med 1975; 293:257.
20. Fallat ME, Siow Y, Belker AM, Boyd JK, Yoffe S, MacLaughlin DT. The presence of mullerian inhibiting substance in human seminal plasma. Hum Reprod 1996;11:2165-2169.
21. Fei Q, Huang X, Zhang L, Li C. The predictive value of serum inhibin B for successful testicular sperm extraction in patients with non-obstructive azoospermia. Chin J Androl 2006;20:25-27.
22. Fenichel P, Rey R, Poggioli S, Donzeau M, Chevallier D, Pointis G. Anti-Mullerian hormone as a seminal marker for spermatogenesis in non-obstructive azoospermia. Hum Reprod 1999;14:2020-2024.
23. Ferhi K, Avakian R, Griveau JF, Guille F. Age as only predictive factor for successful sperm recovery in patients with Klinefelter's syndrome. Andrologia 2009;41:84-87.
24. Foresta C, Bettella A, Petraglia F, Pistorello M, Luisi S, Rossato M. Inhibin B levels in azoospermic subjects with cytologically characterized testicular pathology. Clin Endocrinol (Oxf) 1999;50:695-701.
25. Fujisawa M, Yamasaki T, Okada H, Kamidono S. The significance of anti-Mullerian hormone concentration in seminal plasma for spermatogenesis. Hum Reprod 2002;17:968-970.
26. Goulis DG, Polychronou P, Mikos T, Grimbizis G, Gerou S, Pavlidou V, Papanikolaou A, Tarlatzis BC, Bontis IN, Papadimas I. Serum inhibin-B and follicle stimulating hormone as predictors of the presence of sperm in testicular fine needle aspirate in men with azoospermia. Hormones (Athens) 2008;7:140-147.
27. Goulis DG, Tsametis C, Iliadou PK, Polychronou P, Kantartzi PD, Tarlatzis BC, Bontis IN, Papadimas I. Serum inhibin B and anti-Mullerian hormone are not superior to follicle-stimulating hormone as predictors of the presence of sperm in testicular fine-needle aspiration in men with azoospermia. Fertil Steril 2009; 91:1279-1284.
28. Grimes DA, Schulz KF. Refining clinical diagnosis with likelihood ratios. Lancet 2005;365:1500-1505.
29. Halder A, Fauzdar A, Kumar A. Serum inhibin B and follicle-stimulating hormone levels as markers in the evaluation of azoospermic men: a comparison. Andrologia 2005;37:173-179.
30. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
31. Illingworth PJ, Groome NP, Byrd W, Rainey WE, McNeilly AS, Mather JP, Bremner WJ. Inhibin-B: a likely candidate for the physiologically important form of inhibin in men. J Clin Endocrinol Metab 1996; 81:1321-1325.
32. Isikoglu M, Ozgur K, Oehninger S, Ozdem S, Seleker M. Serum anti-Mullerian hormone levels do not predict the efficiency of testicular sperm retrieval in men with non-obstructive azoospermia. Gynecol Endocrinol 2006;22:256-260.
33. Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 1994;271:703-707.
34. Jensen TK, Andersson AM, Hjollund NH, Scheike T, Kolstad H, Giwercman A, Henriksen TB, Ernst E, Bonde JP, Olsen J et al. Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men. J Clin Endocrinol Metab 1997;82:4059-4063.
35. Koga M, Tsujimura A, Takeyama M, Kiuchi H, Takao T, Miyagawa Y, Takada S, Matsumiya K, Fujioka H, Okamoto Y et al. Clinical comparison of successful and failed microdissection testicular sperm extraction in patients with nonmosaic Klinefelter syndrome. Urology 2007;70:341-345.
36. La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, Stabile G, Volpe A. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 2010;16:113-130.
37. Lee MM, Donahoe PK. Mullerian inhibiting substance: a gonadal hormone with multiple functions. Endocr Rev 1993;14:152-164.
38. Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, Hasegawa Y, Noto RA, Schoenfeld D, MacLaughlin DT. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 1996;81:571-576.
39. Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM. Systematic reviews of diagnostic test accuracy. Ann Intern Med 2008;149:889-897.
40. Liu YC, Cai ZM, Li XX, Li R, He R, Wu XH, Chen ZB, Zhou JT. Predictive value of serum inhibin B levels as an indicator of the presence of testicular spermatozoa in nonobstructive azoospermia. Zhonghua Nan Ke Xue 2006;12:410-412.
41. Mitchell V, Boitrelle F, Pigny P, Robin G, Marchetti C, Marcelli F, Rigot JM. Seminal plasma levels of anti-Mullerian hormone and inhibin B are not predictive of testicular sperm retrieval in nonobstructive azoospermia: a study of 139 men. Fertil Steril 2010; doi 10.1016/j.fertnstert.2009.11.046.
42. Mostafa T, Amer MK, Abdel-Malak G, Nsser TA, Zohdy W, Ashour S, El-Gayar D, Awad HH. Seminal plasma anti-Mullerian hormone level correlates with semen parameters but does not predict success of testicular sperm extraction (TESE). Asian J Androl 2007;9:265-270.
43. Muttukrishna S, Yussoff H, Naidu M, Barua J, Arambage K, Suharjono H, Sathanandan M. Serum anti-Mullerian hormone and inhibin B in disorders of spermatogenesis. Fertil Steril 2007;88:516-518.
44. Nagata Y, Fujita K, Banzai J, Kojima Y, Kasima K, Suzuki M, Tanaka K. Seminal plasma inhibin-B level is a useful predictor of the success of conventional testicular sperm extraction in patients with non-obstructive azoospermia. J Obstet Gynaecol Res 2005;31:384-388.
45. Nowroozi MR, Radkhah K, Ayati M, Jamshidian H, Ranjbaran A, Jabalameli P. Serum inhibin B concentration as a prognostic factor for prediction of sperm retrieval in testis biopsy of patients with azoospermia. Arch Iran Med 2008;11:54-56.
46. Pierik FH, Vreeburg JT, Stijnen T, De Jong FH, Weber RF. Serum inhibin B as a marker of spermatogenesis. J Clin Endocrinol Metab 1998; 83:3110-3114.
47. Pierik FH, Burdorf A, de Jong FH, Weber RF. Inhibin B: a novel marker of spermatogenesis. Ann Med 2003;35:12-20.
48. Ramos L, De Boer P, Meuleman EJ, Braat DD, Wetzels AM. Evaluation of ICSI-selected epididymal sperm samples of obstructive azoospermic males by the CKIA system. J Androl 2004;25:406-411.
49. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 2005;58:982-990.
50. Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 2001; 20:2865-2884.
51. Smit M, Dohle GR, Wildhagen MF, Weber RF. Can inhibin-B predict the outcome of microsurgical epididymal sperm aspiration in patients with suspected primary obstructive azoospermia. Asian J Androl 2007; 9:382-387.
52. Swets JA. Measuring the accuracy of diagnostic systems. Science 1988; 240:1285-1293.
53. Tsujimura A, Matsumiya K, Miyagawa Y, Takao T, Fujita K, Koga M, Takeyama M, Fujioka H, Okuyama A. Prediction of successful outcome of microdissection testicular sperm extraction in men with idiopathic nonobstructive azoospermia. J Urol 2004;172:1944-1947.
54. Tsujimura A, Miyagawa Y, Takao T, Fujita K, Komori K, Matsuaka Y, Takada S, Koga M, Takeyama M, Fujioka H et al. Impact of age, follicle stimulating hormone and Johnsen's score on successful sperm retrieval by microdissection testicular sperm extraction. Reprod Med Biol 2005;4:53-57.
55. Tunc L, Kirac M, Gurocak S, Yucel A, Kupeli B, Alkibay T, Bozkirli I. Can serum Inhibin B and FSH levels, testicular histology and volume predict the outcome of testicular sperm extraction in patients with non-obstructive azoospermia? Int Urol Nephrol 2006;38:629-635.
56. Tuttelmann F, Dykstra N, Themmen AP, Visser JA, Nieschlag E, Simoni M. Anti-Mullerian hormone in men with normal and reduced sperm concentration and men with maldescended testes. Fertil Steril 2009; 91:1812-1819.
57. Vernaeve V, Tournaye H, Schiettecatte J, Verheyen G, Van Steirteghem A, Devroey P. Serum inhibin B cannot predict testicular sperm retrieval in patients with non-obstructive azoospermia. Hum Reprod 2002; 17:971-976.
58. von Eckardstein S, Simoni M, Bergmann M, Weinbauer GF, Gassner P, Schepers AG, Nieschlag E. Serum inhibin B in combination with serum follicle-stimulating hormone (FSH) is a more sensitive marker than serum FSH alone for impaired spermatogenesis in men, but cannot predict the presence of sperm in testicular tissue samples. J Clin Endocrinol Metab 1999;84:2496-2501.
59. Walter SD. The partial area under the summary ROC curve. Stat Med 2005;24:2025-2040.
60. Westlander G, Ekerhovd E, Bergh C. Low levels of serum inhibin B do not exclude successful sperm recovery in men with nonmosaic Klinefelter syndrome. Fertil Steril 2003;79(Suppl. 3):1680-1682.
61. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25.
62. Yalti S, Gurbuz B, Ficicioglu C. Serum levels of inhibin B in men and their relationship with gonadal hormones, testicular volume, testicular biopsy results and sperm parameters. J Obstet Gynaecol 2002;22:649-654.
63. Zhang WX, Wang R, Li PQ. Concentration of seminal plasma and serum inhibin B: a predictor in the diagnosis of azoospermia. Zhonghua Nan Ke Xue 2007;13:598-600.
64. Ziaee S, Ezzatnegad M, Nowroozi M, Jamshidian H, Abdi H, Hosseini Moghaddam SM. Prediction of successful sperm retrieval in patients with nonobstructive azoospermia. Urol J 2006;3:92-96.
65. Zitzmann M, Nordhoff V, von Schonfeld V, Nordsiek-Mengede A, Kliesch S, Schuring AN, Luetjens CM, Kamischke A, Cooper T, Simoni M et al. Elevated follicle-stimulating hormone levels and the chances for azoospermic men to become fathers after retrieval of elongated spermatids from cryopreserved testicular tissue. Fertil Steril 2006;86:339-347.